Malondialdehyde-Modified LDL as a Marker of Acute Coronary Syndromes
Article Abstract:
Measuring blood levels of malondialdehyde (MDA)-modified low-density lipoprotein (LDL) and myocardial troponin I may distinguish patients with stable coronary artery disease (CAD) and those with unstable angina or a heart attack. MDA-LDL and troponin I are produced by damage to the heart. In a study of 104 patients with a history of CAD, the production of MDA-LDL and troponin I was 98% accurate in detecting patients with unstable angina and 100% accurate in diagnosing a heart attack. The absence of MDA-LDL and troponin was 99% accurate in detecting patients with stable CAD.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Troponins in acute coronary syndromes: More tactics for an early invasive strategy
Article Abstract:
Patients with symptoms of a heart attack who also have increased blood levels of cardiac troponins have a high risk of death and should be treated with angioplasty. Troponins are proteins produced by the heart when it is damaged. However, the tests for troponin can produce different results, and many medical conditions can cause a false-negative or false-positive result.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Healing achilles-sirolimus versus paclitaxel
Article Abstract:
The findings from randomized, head-to-head comparisons of a sirolimus-eluting stent with a paclitaxel-eluting stent are presented. The data overall from randomized clinical trials and from registries suggests that the currently available sirolimus-eluting stents provide an angiographic and clinical edge over the currently available paclitaxel-eleuting stents.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Biologic modifiers and chemoprevention of cancer of the oral cavity. DNA content as a prognostic marker in patients with oral leukoplakia
- Abstracts: Catabolic illness: strategies for enhancing recovery. Occupational illness. High-altitude illness
- Abstracts: Vitamin A Deficiency Among Children--Federated States of Micronesia, 2000. Kernicterus in Full-Term Infants--United States, 1994-1998
- Abstracts: Oral galvanism in Sweden. Oral cancer growth factor found
- Abstracts: The changing face of infectious disease: New threats, new science. Leukemia: steady progress brightens outlook on blood disease